SYSTEM SUPPORT IN THE FORMING AND GROWTH OF HAIR IN ALOPECIAS
AND THE DISORDERS OF HAIR SHAFT
About the author:	L.D. Kaliuzhna, L.V. Hrechanska, A.V. Petrenko	
Heading	clinical observations	
Type of article	Research Article	
Annotation	The objective: сlinical and microscopic observation of the condition of hair in various 
forms of alopecia by including in the treatment protocol of the drug Natubiotin.
Materials and methods. 22 patients with various hair diseases were observed 
(10 patients with alopecia areata, 2 patients with anagen alopecia, 2 with telogen 
alopecia, 5 with androgenetic alopecia, 1 was diagnosed with nodular trichorexia, 2 
with trichotillomania),the duration of the pathological process in patients exceeded 
3 years. The use of Natubiotin, which has a significant potential in the
form of keratin and biotin, should affect the restoration of the disturbed biological
cascade.
Results. In anagen alopecia, the Natubiotin was administered simultaneously with
 detoxification therapy. This therapy was taken by patients for 1 to 4 months.
 Natubiotin was prescribed to patients with alopecia areata along with physiotherapy,
 cryotherapy. This course has paid off, and in the dynamic observation there was a 
steady positive effect. In androgenetic alopecia, Natubiotin can help strengthen
the structure of miniaturized hair. Natubiotin showed a positive result in the treatment 
of disorders of the structure of the hair shaft.
Conclusions. The use of Natubiotin allowed in combination with emollients and 
shampoos to get the result in the form of strengthening the hair, restoring their 
number in telogen and anagen alopecia. Thus, knowledge of hair pathology, the 
ability to make a differential diagnosis allow the doctor to plan a reasonable adequate
 treatment of hair diseases	
Tags	 naftifine hydrochloride, Exik, dermatomycosis, foot mycoses	
Bibliography	1. Kaliuzhna LD. Khvoroby pokhidnykh shkiry (The diseases of skin glandes and hair). Hramota, 2008. 119 р.
2. Kaliuzhna LD. Zabuta problema zakhvoriuvannia volossia – alopetsiia v Chernivtsiakh (A forgotten problem of hair disease is alopecia in Chernivtsi). Ukrainian Journal of Dermatology, Venereology, Cosmetology. 2018. P. 106–109.
3. Ruk A, Dauber R. Bolezni volos i volosistoj chasti golovy’ (Diseases of the hair and scalp). Moscow: Mediczina, 1985. 528 p.
4. Vano-Galvan S, Fernandes-Crehuat P, Grimalt R, et al. Alopecia areata totalis and universalis: a multicenter review of 132 patients in Spain. Journ Europ Derm Vener. 2017;31:550–556.
5. Birch MD, Messenger JF, Messenger AG. Hair Density, hair diameter and prevalence of female pattern hair loss. Brit. J. Dermatol. 2001;144:297–304.
6. Camacho FM, Garcia-Hernandez MJ. Zink aspartate, biotin and clobetasol propionate in the treatment of alopecia areata in childhood. Pediatr Dermatol. 1999;16:336–338.
7. Dawber R, Van Neste D. Hair and Scalp Disorders. Martin Dunitz, UK, 1997. 262 p.
8. Epstein P, Cotsarelis G. The biology of hair follicles. New England Journal of Medicine. 1999;341:491–497.
9. Guarrera M. Chronic telogen effluvium. Journal of Europian Academy of Dermatology and Venerology. 2000;14:36.
10. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, et al. Guidlines of care for androgenetic alopecia. Journal of the American Academy Dermatology. 1996;38(3):465–468.
11. Kim MW, Shin IS, Yoon HS, Cho S, Park HS. Lipide profile in patients with androgenetic alopecia: a meta-analysis. J Europ Acad Dermatol Vener. 2017;31:942–951.
12. Pierard-Francheinont C, Pierard GE. The actinic telogen effluvium: a chronobiological threat. Journal of Eur Acad Derm Vener. 1999;12:47–49.
13. Rudnicka L, Rakowska A. Dyslipidemia in patients with androgenetic alopecia. Statins, finasteride or both? Journ Acad derm Vener. 2017;31:921–922.
14. Spano F, Donovan JC. Alopecia areata: Part I: pathogenesis? Diagnosis and prognosis. Can Fam Physician. 2015;61:751–755.
15. Whiting DA. Chronic telogen effluvium: Increased scalp hair shedding in middle-aged women. Journ Amer Acad Derm. 1996;35(6):899–906.
16. Wolff H. Male and female androgenetic alopecia. In: Evidence-based Dermatology.Blackwell, 2008. P. 513–517.	
Publication of the article	«DERMATOLOGY AND VENEREOLOGY» №2(88), 2020 year, 29-34 pages,
 index UDK 616.59	
DOI	10.33743/2308-1066-2020-2-29-34